Michael S. Anderson
CEO and director
formulation development
Avadel Pharmaceuticals plc (AVDL)Â
Ireland
Biography
Mr. Michael S. Anderson, also known as Mike, has been the Chief Executive Officer of Avadel Pharmaceuticals plc (also known as Flamel Technologies SA) since March 13, 2012. Mr. Anderson has over 46 years of experience. He served as Chief Executive Officer at Eclat Pharmaceuticals. He served as President and Chief Executive Officer of the generic business division of KV Pharmaceutical Company. He served as President and Chief Executive Officer of Ther-RX Corporation. He started his career at A.H. Robins Company. He has been a Director of Avadel Pharmaceuticals plc since June 2012.
Research Interest
safe and effective drug formulation.
